A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)
Clinical trial NCT04235621 · TERMINATED
Trial details
- NCT number
- NCT04235621
- Sponsor
- Goldfinch Bio, Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-20
- Primary completion
- 2020-05-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.